日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: insights from a multicenter case series

BCMA靶向CAR-T细胞治疗后免疫效应细胞相关性肠炎:来自多中心病例系列的启示

Susanibar-Adaniya, Sandra; Derman, Benjamin A; Cohen, Adam D; Vogl, Dan T; Richard, Shambavi; Rossi, Adriana; Frigualt, Matthew J; Yee, Andrew J; Dhakal, Binod; Bar, Noffar

Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma

卡非佐米四联疗法在治疗新诊断的多发性骨髓瘤中的当前和未来作用

Landgren, Ola; Biran, Noa; O'Donnell, Elizabeth K; Mikhael, Joseph; Weisel, Katja C; Broijl, Annemiek; Usmani, Saad Z; Moreau, Philippe; Gay, Francesca M; Mina, Roberto; Rodríguez-Otero, Paula; Jakubowiak, Andrzej J; Derman, Benjamin A

Early peripheral blood and bone marrow MRD as prognostic markers in quadruplet-treated multiple myeloma without transplant

早期外周血和骨髓微小残留病灶作为未接受移植的四联疗法治疗多发性骨髓瘤患者的预后标志物

Derman, Benjamin A; Cooperrider, Jennifer; Pula, Anna; Simmons, Heidi; Kubicki, Tadeusz; Zonder, Jeffrey; Afrough, Aimaz; Grinblatt, David; Rosenblatt, Jacalyn; Anderson, Larry D Jr; Kin, Andrew; Avigan, David; Narula, Sunil; Rayani, Shayan; Jiang, Ken; Major, Ajay; Karrison, Theodore; Jacob, Allison; Jakubowiak, Andrzej J

Minimal Residual Disease Negativity as the Primary Goal of Multiple Myeloma Therapy

微小残留病灶阴性是多发性骨髓瘤治疗的主要目标

Cooperrider, Jennifer H; Derman, Benjamin A

Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma

多发性骨髓瘤患者接受来那度胺维持治疗期间及停药后克隆性造血的演变

Cooperrider, Jennifer H; Karaoglu, Diren Arda; Kubicki, Tadeusz; Jiang, Can Rui; Postich, Ella; Shimamoto, Kathryn; Arnold, Olivia; Macaraeg, Jommel; Ramsland, Aubrianna; Pula, Anna; Kishtagari, Ashwin; Pershad, Yash; Mack, Taralynn M; Jones, Angela; Bick, Alexander G; Savona, Michael; Drazer, Michael W; Dytfeld, Dominik; Jakubowiak, Andrzej; Derman, Benjamin A; Saygin, Caner

Phase 1 clinical trial of B-Cell Maturation Antigen (BCMA) NEX-T® Chimeric Antigen Receptor (CAR) T cell therapy CC-98633/BMS-986354 in participants with triple-class exposed multiple myeloma

B细胞成熟抗原(BCMA)NEX-T®嵌合抗原受体(CAR)T细胞疗法CC-98633/BMS-986354在接受过三线抗肿瘤治疗的多发性骨髓瘤患者中的I期临床试验

Ravi, Gayathri; Richard, Shambavi; Kumar, Shaji; Atrash, Shebli; Liedtke, Michaela; Kaur, Gurbakhash; Derman, Benjamin; Bergsagel, P Leif; Mailankody, Sham; McCarthy, Philip; Shrestha, Alok; Kelly, Lisa M; Ly, Thomas; Das, Sharmila; Thorpe, Jerill; Maier, Alison; Varun, Divya; Navarro, Garnet; Burgess, Michael R; Hege, Kristen; Koegel, Ashley K; Costa, Luciano J

International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma

国际骨髓瘤工作组免疫治疗委员会关于多发性骨髓瘤治疗免疫疗法顺序的建议

Costa, Luciano J; Banerjee, Rahul; Mian, Hira; Weisel, Katja; Bal, Susan; Derman, Benjamin A; Htut, Maung M; Nagarajan, Chandramouli; Rodriguez, Cesar; Richter, Joshua; Frigault, Matthew J; Ye, Jing C; van de Donk, Niels W C J; Voorhees, Peter M; Puliafito, Benjamin; Bahlis, Nizar; Popat, Rakesh; Chng, Wee Joo; Ho, P Joy; Kaur, Gurbakhash; Kapoor, Prashant; Du, Juan; Schjesvold, Fredrik; Berdeja, Jesus; Einsele, Hermann; Cohen, Adam D; Mikhael, Joseph; Biru, Yelak; Rajkumar, S Vincent; Lin, Yi; Martin, Thomas G; Chari, Ajai

Brain-to-vein and vein-to-vein times and outcomes in CAR T-cell therapy in myeloma

多发性骨髓瘤CAR-T细胞疗法中脑静脉和静脉到静脉的转运时间和结果

Grischke, Tyra K; Cooperrider, Jennifer H; Pula, Anna; Sneider, Abigail; Yates, Samuel; Jakubowiak, Andrzej J; Derman, Benjamin A

Intrathecal chemotherapy for ciltacabtagene autoleucel-associated movement and neurocognitive toxicity

鞘内化疗治疗ciltacabtagene autoleucel相关运动和神经认知毒性

Kelly, Kaitlin; Cooperrider, Jennifer H; Bishop, Michael R; Kosuri, Satyajit; Jakubowiak, Andrzej; Derman, Benjamin A

Clinical applications of mass spectrometry in multiple myeloma

质谱技术在多发性骨髓瘤中的临床应用

Derman, Benjamin A; Yee, Andrew J